Patrick S Sullivan1, Leandro Mena2, Latesha Elopre3, Aaron J Siegler4. 1. Rollins School of Public Health, Department of Epidemiology, Emory University, 1518 Clifton Road NE, Room 464, Atlanta, GA, 30322, USA. pssulli@emory.edu. 2. John D. Bower School of Population Health, Department of Population Health Science, University of Mississippi Medical Center, Jackson, MS, USA. 3. School of Medicine, University of Alabama, Birmingham, AL, USA. 4. Rollins School of Public Health, Department of Behavioral Sciences and Health Education, Emory University, Atlanta, GA, USA.
Abstract
PURPOSE OF REVIEW: Seven years after TDF/FTC was approved for pre-exposure prophylaxis to reduce risks of HIV infection, there have been large increases in the number of persons using PrEP in the USA. However, recent data on pre-exposure prophylaxis (PrEP) use at the state level indicate that people living in the Southern United States are underserved by PrEP relative to their epidemic need. We sought to review possible reasons for inequitable uptake of PrEP in the South and identify implementation approaches to increase PrEP uptake in the South. RECENT FINDINGS: Published literature, data on the locations of PrEP service providers, recent data on PrEP utilization from pharmacy prescription databases, HIV surveillance data and government data on healthcare providers, and health literacy indicate a confluence of factors in the South that are likely limiting PrEP uptake. A variety of approaches are needed to address the complex challenges to PrEP implementation in the South. These include considering alternative PrEP provision strategies (e.g., pharmacy-based PrEP, telemedicine-delivered PrEP), conducting gain-based stigma-reduction campaigns, increasing capacity for reimbursement for PrEP medications and services through policy change to expand Medicaid and to preserve access to Affordable Care Act-compliant health plans, expanding STI screening programs and improving integration of PrEP offering with delivery of positive STI results, using mHealth tools to screen groups at highest risk for HIV (e.g., men who have sex with men) periodically to increase correct perception of risk, and streamlining clinical procedures to allow same-day PrEP starts for patients without obvious medical contraindications. Overcoming the structural, capacity, and policy challenges to increasing PrEP uptake in the South will require innovations in clinical approaches, leveraging technologies, and policy changes. The South has unique challenges to achieving equitable PrEP uptake, and addressing key barriers to expanded PrEP use will require multisectoral responses.
PURPOSE OF REVIEW: Seven years after TDF/FTC was approved for pre-exposure prophylaxis to reduce risks of HIV infection, there have been large increases in the number of persons using PrEP in the USA. However, recent data on pre-exposure prophylaxis (PrEP) use at the state level indicate that people living in the Southern United States are underserved by PrEP relative to their epidemic need. We sought to review possible reasons for inequitable uptake of PrEP in the South and identify implementation approaches to increase PrEP uptake in the South. RECENT FINDINGS: Published literature, data on the locations of PrEP service providers, recent data on PrEP utilization from pharmacy prescription databases, HIV surveillance data and government data on healthcare providers, and health literacy indicate a confluence of factors in the South that are likely limiting PrEP uptake. A variety of approaches are needed to address the complex challenges to PrEP implementation in the South. These include considering alternative PrEP provision strategies (e.g., pharmacy-based PrEP, telemedicine-delivered PrEP), conducting gain-based stigma-reduction campaigns, increasing capacity for reimbursement for PrEP medications and services through policy change to expand Medicaid and to preserve access to Affordable Care Act-compliant health plans, expanding STI screening programs and improving integration of PrEP offering with delivery of positive STI results, using mHealth tools to screen groups at highest risk for HIV (e.g., men who have sex with men) periodically to increase correct perception of risk, and streamlining clinical procedures to allow same-day PrEP starts for patients without obvious medical contraindications. Overcoming the structural, capacity, and policy challenges to increasing PrEP uptake in the South will require innovations in clinical approaches, leveraging technologies, and policy changes. The South has unique challenges to achieving equitable PrEP uptake, and addressing key barriers to expanded PrEP use will require multisectoral responses.
Entities:
Keywords:
HIV prevention; Multisectoral responses; Pre-exposure prophylaxis (PrEP)
Authors: Jelani C Kerr; Robert F Valois; Ralph J Diclemente; Faith Fletcher; Michael P Carey; Daniel Romer; Peter A Vanable; Naomi Farber Journal: AIDS Behav Date: 2014-06
Authors: Jeffrey T Parsons; H Jonathon Rendina; Jonathan M Lassiter; Thomas H F Whitfield; Tyrel J Starks; Christian Grov Journal: J Acquir Immune Defic Syndr Date: 2017-03-01 Impact factor: 3.731
Authors: Catherine E Oldenburg; Amaya G Perez-Brumer; Mark L Hatzenbuehler; Douglas Krakower; David S Novak; Matthew J Mimiaga; Kenneth H Mayer Journal: AIDS Date: 2015-04-24 Impact factor: 4.177
Authors: Annie Lockard; Eli S Rosenberg; Patrick S Sullivan; Colleen F Kelley; David P Serota; Charlotte-Paige M Rolle; Nicole Luisi; Emily Pingel; Aaron J Siegler Journal: AIDS Patient Care STDS Date: 2019-03 Impact factor: 5.078
Authors: Charlotte A Gaydos; Karen Dwyer; Mathilda Barnes; Patricia A Rizzo-Price; Billie Jo Wood; Toni Flemming; M Terry Hogan Journal: Sex Transm Dis Date: 2006-07 Impact factor: 2.830
Authors: Dawn K Smith; Michelle Van Handel; Richard J Wolitski; Jo Ellen Stryker; H Irene Hall; Joseph Prejean; Linda J Koenig; Linda A Valleroy Journal: MMWR Morb Mortal Wkly Rep Date: 2015-11-27 Impact factor: 17.586
Authors: Daniel Grace; Jody Jollimore; Paul MacPherson; Matthew J P Strang; Darrell H S Tan Journal: AIDS Patient Care STDS Date: 2017-11-29 Impact factor: 5.078
Authors: Daniel Resnick; Marilyn M Schapira; Mary E Andrews; Amadi Essoka-Lasenberry; Annet Davis-Vogel; José A Bauermeister; Sarah M Wood Journal: AIDS Educ Prev Date: 2022-02
Authors: Aaron J Siegler; C Christina Mehta; Farah Mouhanna; Robertino Mera Giler; Amanda Castel; Elizabeth Pembleton; Chandni Jaggi; Jeb Jones; Michael R Kramer; Pema McGuinness; Scott McCallister; Patrick S Sullivan Journal: Ann Epidemiol Date: 2020-04-03 Impact factor: 3.797
Authors: Rebecca Rossetti; Tara Smith; Wei Luo; Jennifer Taussig; Mariah Valentine-Graves; Patrick Sullivan; Jessica M Ingersoll; Colleen S Kraft; Steve Ethridge; Laura Wesolowski; Kevin P Delaney; S Michele Owen; Jeffrey A Johnson; Silvina Masciotra Journal: J Clin Virol Date: 2020-06-01 Impact factor: 3.168
Authors: Christine M Khosropour; Kandis V Backus; Arianna R Means; Laura Beauchamps; Kendra Johnson; Matthew R Golden; Leandro Mena Journal: AIDS Patient Care STDS Date: 2020-01 Impact factor: 5.078
Authors: Audrey Harkness; Satyanand Satyanarayana; Daniel Mayo; Rosana Smith-Alvarez; Brooke G Rogers; Guillermo Prado; Steven A Safren Journal: AIDS Patient Care STDS Date: 2021-05 Impact factor: 5.078
Authors: Krishna Kiran Kota; Gordon Mansergh; Rob Stephenson; Sabina Hirshfield; Patrick Sullivan Journal: AIDS Patient Care STDS Date: 2021-04-23 Impact factor: 5.078
Authors: Wenting Huang; Annie Lockard; Colleen F Kelley; David P Serota; Charlotte-Paige M Rolle; Patrick S Sullivan; Eli S Rosenberg; Aaron J Siegler Journal: AIDS Care Date: 2021-08-09